Abstract
Introduction
Questions persist regarding the relative effectiveness of injectable collagenase (CCH) in the treatment of Dupuytren contracture. This study assessed the effectiveness of CCH as compared with limited fasciectomy (LF) in clinical practice.
Methods
We evaluated patients who underwent CCH or LF for metacarpophalangeal (MP) and/or proximal interphalangeal (PIP) joint contractures between 2011 and 2014 at 7 practice sites. We compared the degree of residual contracture (active extension deficit), Michigan Hand Questionnaire (MHQ) scores, and adverse events at follow-up visits occurring between 6 and 12 weeks after surgery or the last injection after matching patients based on their individual propensity scores.
Results
An analysis of 132 matched patients undergoing CCH (N = 66) or LF (N = 66) showed that the degree of residual contracture for affected MP joints was not significantly different at follow-up (13° vs. 6°, P = 0.095). Affected PIP joints, however, showed worse residual contracture after CCH than after LF (25° vs. 15°, P = 0.010). CCH patients experienced fewer serious adverse events than did LF patients and reported larger improvements in the MHQ subscores of satisfaction, activities in daily life, and work performance.
Conclusions
CCH provides an alternative to LF for patients with MP contractures and those with affected PIP joints who are willing to trade slightly better contracture correction for faster recovery of hand function and a lower risk of serious adverse events.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Atroshi I, Strandberg E, Lauritzson A et al (2014) Costs for collagenase injections compared with fasciectomy in the treatment of Dupuytren’s contracture: a retrospective cohort study. BMJ Open 4(1):e004166
Becker GW, Davis TR (2010) The outcome of surgical treatments for primary Dupuytren’s disease – a systematic review. J Hand Surg Eur Vol 35(8):623–626
Chung KC, Hamill JB, Walters MR, Hayward RA (1999) The Michigan Hand Outcomes Questionnaire (MHQ): assessment of responsiveness to clinical change. Ann Plast Surg 42(6):619–622
Clapham PJ, Pushman AG, Chung KC (2010) A systematic review of applying patient satisfaction outcomes in plastic surgery. Plast Reconstr Surg 125(6):1826–1833
Dias JJ, Braybrooke J (2006) Dupuytren’s contracture: an audit of the outcomes of surgery. J Hand Surg Br 31(5):514–521
Dias JJ, Singh HP, Ullah A et al (2013) Patterns of recontracture after surgical correction of Dupuytren disease. J Hand Surg Am 38(10):1987–1993
Dreise MM, Stenekes MW, Werker PM (2016) Collagenase treatment for dupuytren disease of the thumb and first web. J Hand Surg Am 41:348–353.e1. doi:10.1016/j.jhsa.2015.12.003
Engstrand C, Krevers B, Nylander G, Kvist J (2014) Hand function and quality of life before and after fasciectomy for Dupuytren contracture. J Hand Surg Am 39(7):1333–1343, e1332
Freemantle N, Marston L, Walters K et al (2013) Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research. BMJ 347:f6409
Gaston RG, Larsen SE, Pess GM et al (2015) The efficacy and safety of concurrent collagenase clostridium histolyticum injections for 2 dupuytren contractures in the same hand: a prospective, multicenter study. J Hand Surg Am 40(10):1963–1971
Gilpin D, Coleman S, Hall S et al (2010) Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren’s disease. J Hand Surg Am 35(12):2027–2038, e2021
Henry M (2014) Dupuytren’s disease: current state of the art. Hand (N Y) 9(1):1–8
Hurst LC, Badalamente MA, Hentz VR et al (2009) Injectable collagenase clostridium histolyticum for Dupuytren’s contracture. N Engl J Med 361(10):968–979
Kan HJ, Verrijp FW, Huisstede BM et al (2013) The consequences of different definitions for recurrence of Dupuytren’s disease. J Plast Reconstr Aesthet Surg 66(1):95–103
London DA, Stepan JG, Calfee RP (2014) Determining the michigan hand outcomes questionnaire minimal clinically important difference by means of three methods. Plast Reconstr Surg 133(3):616–625
Murphy A, Lalonde DH, Eaton C et al (2014) Minimally invasive options in Dupuytren’s contracture: aponeurotomy, enzymes, stretching, and fat grafting. Plast Reconstr Surg 134(5):822e–829e
Naam NH (2013) Functional outcome of collagenase injections compared with fasciectomy in treatment of Dupuytren’s contracture. Hand (N Y) 8(4):410–416
Nydick JA, Olliff BW, Garcia MJ et al (2013) A comparison of percutaneous needle fasciotomy and collagenase injection for dupuytren disease. J Hand Surg Am 38(12):2377–2380
Peimer CA, Blazar P, Coleman S et al (2013a) Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data. J Hand Surg Am 38(1):12–22
Peimer CA, Skodny P, Mackowiak JI (2013b) Collagenase clostridium histolyticum for dupuytren contracture: patterns of use and effectiveness in clinical practice. J Hand Surg Am 38(12):2370–2376
Peimer CA, Wilbrand S, Gerber RA et al (2015) Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren’s contracture. J Hand Surg Eur Vol 40:141–149, 1753193414528843
Preisser JS, Lohman KK, Rathouz PJ (2002) Performance of weighted estimating equations for longitudinal binary data with drop-outs missing at random. Stat Med 21(20):3035–3054
Rothwell PM (2005) External validity of randomised controlled trials: to whom do the results of this trial apply? Lancet 365(9453):82–93
Rubin DB (2007) The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials. Stat Med 26(1):20–36
Thoma A, Kaur MN, Ignacy TA et al (2014) Health-related quality of life in patients undergoing palmar fasciectomy for Dupuytren’s disease. Plast Reconstr Surg 133(6):1411–1419
van Loon J, Kemler MA, Nagel PH et al (2012) Dupuytren’s disease guideline. Dutch Soc Plast Surg pp 17–18.
van Rijssen AL, Gerbrandy FS, Ter Linden H et al (2006) A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren’s disease: a 6-week follow-up study. J Hand Surg Am 31(5):717–725
Volpp KG (2009) Comparative effectiveness – thinking beyond medication a versus medication B. N Engl J Med 361(4):331–333
Warwick D, Arner M, Pajardi G et al (2014) Collagenase Clostridium histolyticum in patients with Dupuytren’s contracture: results from POINT X, an open-label study of clinical and patient-reported outcomes. J Hand Surg Eur Vol. doi:10.1177/1753193413519926
Werker PM, Pess GM, van Rijssen AL, Denkler K (2012) Correction of contracture and recurrence rates of Dupuytren contracture following invasive treatment: the importance of clear definitions. J Hand Surg Am 37(10):2095–2105, e2097
Witthaut J, Jones G, Skrepnik N et al (2013) Efficacy and safety of collagenase clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies. J Hand Surg Am 38(1):2–11
Zeger SL, Liang KY (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42(1):121–130
Zhou C, Hovius SE, Slijper HP, et al. Collagenase Clostridium Histolyticum versus Limited Fasciectomy for Dupuytren’s Contracture: Outcomes from a Multicenter Propensity Score Matched Study. Plastic and reconstructive surgery 2015;136:87–97.
Zhou C, Selles RW, Slijper HP, et al. Comparative Effectiveness of Percutaneous Needle Aponeurotomy and Limited Fasciectomy for Dupuytren’s contracture: A Multicenter Observational Study. Plastic and reconstructive surgery (in press).
Conflicts of Interest Declaration
We declare that several coauthors (S.E.R.H., R.W.S., R.F.) have been consultants to Pfizer and Sobi, two manufacturers of injectable collagenase in Europe, after agreeing not to personally receive any form of financial compensation for their advisory services. Support was received from Pfizer in the form that the injections used in the present study were provided free of charge. To ensure objectivity, the present study was conducted without any involvement from both pharmaceutical companies.
This chapter is an extended and updated version of the paper Zhou C et al. (2015) Collagenase Clostridium Histolyticum versus Limited Fasciectomy for Dupuytren’s Contracture: Outcomes from a Multicenter Propensity Score Matched Study. Plast reconstr surg 136:87–97 and is reproduced with permission of the American Plastic Surgery Society and Wolter Kluwer.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Zhou, C. et al. (2017). Comparative Effectiveness of Collagenase Injection for Dupuytren Contracture. In: Werker, P., Dias, J., Eaton, C., Reichert, B., Wach, W. (eds) Dupuytren Disease and Related Diseases - The Cutting Edge. Springer, Cham. https://doi.org/10.1007/978-3-319-32199-8_35
Download citation
DOI: https://doi.org/10.1007/978-3-319-32199-8_35
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32197-4
Online ISBN: 978-3-319-32199-8
eBook Packages: MedicineMedicine (R0)